Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

• Published in: Clinical and Vaccine Immunology Vol. 19; no. 2; pp. 140 - 145
• Main Authors: Bellanti, Joseph A, Lin, Feng-Ying C, Chu, Chiayung, Shiloach, Joseph, Leppla, Stephen H, Benavides, German A, Karpas, Arthur, Moayeri, Mahtab, Guo, Chunyan, Robbins, John B, Schneerson, Rachel
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01-02-2012
• Subjects: Adjuvants, Immunologic - administration & dosage; Adolescent; Adult; Anthrax - immunology; Anthrax - prevention & control; Anthrax Vaccines - administration & dosage; Anthrax Vaccines - adverse effects; Anthrax Vaccines - immunology; Antibodies, Bacterial - blood; Antibody Formation; Antigens, Bacterial - immunology; Bacillus anthracis - immunology; Bacterial Toxins - immunology; Female; Humans; Male; Middle Aged; Recombinant Proteins - immunology; Vaccines; Vaccines, Synthetic - administration & dosage; Vaccines, Synthetic - adverse effects; Vaccines, Synthetic - immunology; Young Adult
• ISSN: 1556-6811; 1556-679X
• DOI: 10.1128/CVI.05556-11

Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • [e-mail]
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.  
For an alternate route to
CVI
.asm.org, visit:
CVI